Variant report
Variant | rs6704865 |
---|---|
Chromosome Location | chr2:20431928-20431929 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:20426000-20447000 | Weak transcription | GM12878-XiMat | blood |
2 | chr2:20426200-20436600 | Weak transcription | Pancreas | Pancrea |
3 | chr2:20426400-20436800 | Enhancers | Placenta | Placenta |
4 | chr2:20430400-20432200 | Enhancers | HMEC | breast |
5 | chr2:20430600-20432800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
6 | chr2:20430800-20432600 | Enhancers | Stomach Mucosa | stomach |
7 | chr2:20431000-20432000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
8 | chr2:20431000-20433000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr2:20431000-20433000 | Enhancers | H1 Cell Line | embryonic stem cell |
10 | chr2:20431000-20433000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr2:20431000-20433000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr2:20431000-20433000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr2:20431000-20433400 | Enhancers | Placenta Amnion | Placenta Amnion |
14 | chr2:20431200-20432800 | Flanking Active TSS | NHEK | skin |
15 | chr2:20431400-20432000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr2:20431400-20432000 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
17 | chr2:20431400-20432000 | Flanking Active TSS | Hela-S3 | cervix |
18 | chr2:20431400-20432600 | Enhancers | Duodenum Mucosa | Duodenum |
19 | chr2:20431400-20435600 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
20 | chr2:20431400-20446800 | Weak transcription | Spleen | Spleen |
21 | chr2:20431600-20432000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
22 | chr2:20431600-20432200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
23 | chr2:20431600-20432800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
24 | chr2:20431600-20433000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
25 | chr2:20431600-20435400 | Weak transcription | Colonic Mucosa | Colon |
26 | chr2:20431600-20435600 | Weak transcription | Gastric | stomach |
27 | chr2:20431600-20440600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
28 | chr2:20431800-20432000 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
29 | chr2:20431800-20432200 | Weak transcription | H9 Cell Line | embryonic stem cell |
30 | chr2:20431800-20432200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
31 | chr2:20431800-20432200 | Enhancers | HepG2 | liver |
32 | chr2:20431800-20433800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
33 | chr2:20431800-20435400 | Weak transcription | Esophagus | oesophagus |
34 | chr2:20431800-20435600 | Weak transcription | Lung | lung |
35 | chr2:20431800-20444200 | Weak transcription | A549 | lung |
36 | chr2:20431800-20446200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |